Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study

Dr. Cortese discusses research on the effect of vitamin D levels via cod l…

Expiration Date: 2/5/2016

Max Credits: 0

View Activity

Real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian Multiple Sclerosis Treatment Registry

Real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian Multiple Sclerosis Treatment Registry

Dr. Guger discusses the most current research on the use of natalizumab an…

Expiration Date: 2/5/2016

Max Credits: 0

View Activity

Increased neutralization capacity of TNF-α in sera of MS patients may play a role in MS pathogenesis and is reversed by therapy with interferon-β

Increased neutralization capacity of TNF-α in sera of MS patients may play a role in MS pathogenesis and is reversed by therapy with interferon-β

Dr. Karni discusses the role of TNF-alpha in MS…

Expiration Date: 12/16/2019

Max Credits: 0

View Activity

Multiple Sclerosis and Women’s Health: Dispelling Myths and Improving Care

Multiple Sclerosis and Women’s Health: Dispelling Myths and Improving Care

Multiple sclerosis (MS), a chronic inflammatory disease of the central ner…

Expiration Date: 1/22/2016

Max Credits: 0

View Activity

Early brain volume loss on interferon predicts disability progression after 4 years

Early brain volume loss on interferon predicts disability progression after 4 years

Dr. Pérez-Miralles discusses the early implications of brain volume losses…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Treatment strategies – determining treatment failure, what to do next

Treatment strategies – determining treatment failure, what to do next

Dr. Miller discusses defining treatment failure discussing subsequent trea…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Optimizing Patient Safety and Outcomes by Individualizing Therapy

Optimizing Patient Safety and Outcomes by Individualizing Therapy

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Making Informed Decisions When Screening and Monitoring

Making Informed Decisions When Screening and Monitoring

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study

No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study

Dr. Coyle discusses the most current research on the effect of interferon …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Long-term effects of fampridine on walking ability in patients with multiple sclerosis: a phase II, open-label, uncontrolled, monocenter study

Long-term effects of fampridine on walking ability in patients with multiple sclerosis: a phase II, open-label, uncontrolled, monocenter study

Dr. Filli discusses the most current research on the effect of fampridine …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity